Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof
Patents for C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof (30,692)
09/2005
09/22/2005US20050209150 Compositions and methods for inhibiting abnormal cell growth
09/22/2005US20050209146 Administering bifunctional molecules containing a drug moiety and presenter protein ligand for therapy
09/22/2005US20050209135 Etherification of an N-protected-2-carboxyl-4-hydroxypyrrolidine with a 4-halo-quinolone, amidation with a 1-amino-2-vinylcylcopropane, deprotecting the ring nitrogen, amidation with a 7-octenoic acid, ring closing metathesis with 2nd generation Hoveyda's catalyst; one pot process; Hepatitis C viricides
09/22/2005US20050209134 Novel depsipeptide compound
09/22/2005US20050208589 Branched peptide amphiphiles, related epitope compounds and self assembled structures thereof
09/22/2005US20050208140 A di, tri or oligopeptide covalently bonded with an active agent ( therapeutical agent, contrast agent or fluorescent dye) from a side chain of the intermediate or C-terminus amino acid
09/22/2005US20050207981 Compositions and methods for determining substrate specificity of hydrolytic enzymes
09/22/2005CA2557495A1 Sulfur compounds as inhibitors of hepatitis c virus ns3 serine protease
09/22/2005CA2557307A1 3,4-(cyclopentyl)-fused proline compounds as inhibitors of hepatitis c virus ns3 serine protease
09/22/2005CA2557249A1 Novel compounds as inhibitors of hepatitis c virus ns3 serine protease
09/22/2005CA2557247A1 Compounds as inhibitors of hepatitis c virus ns3 serine protease
09/22/2005CA2555792A1 Therapeutic administration of the scrambled anti-angiogenic peptide c16y
09/21/2005EP1577320A1 Peptides derived from human BPLP protein, polynucleotides coding for said peptides and antibodies directed against said peptides
09/21/2005EP1576113A2 Tumor antigens bfa4 and bcy1 for prevention and/or treatment of cancer
09/21/2005EP1576104A2 Nucleic acids and corresponding proteins entitled 202p5a5 useful in treatment and detection of cancer
09/21/2005EP1575994A2 Mage-c2 antigenic peptides and uses thereof
09/21/2005EP1575991A2 Peptides comprising aromatic d-amino acids and methods of use
09/21/2005EP1575900A1 N-methyl amino acids
09/21/2005EP1575867A2 Peptide nanostructures and methods of generating and using the same
09/21/2005EP1575605A1 Cosmetic or pharmaceutical composition comprising peptides with the sequence arg-gly-ser
09/21/2005EP1575602A2 Methods for treating cancer using porimin as a target
09/21/2005EP1575524A2 Proliferated cell lines and uses thereof
09/21/2005EP1575496A2 Colon tumor specific binding peptides
09/21/2005EP1575375A1 Ace inhibitory peptides from plant materials
09/21/2005EP1019533B1 Silanol enzyme inhibitors
09/21/2005CN1671840A Novel enzyme forming peptide, microorganism producing the same and process for producing dipeptide using them
09/21/2005CN1671654A Gelling agents
09/20/2005US6946562 Solid phase synthesis of ballasted dye-forming azole couplers including reacting amino functionalized azole compound with polystyrene bound peptoid oligomer, then cleaving from the resin surface with fluorinated acid solvent
09/20/2005US6946480 Glutaminyl based DPIV inhibitors
09/20/2005US6946459 Crystalline forms of 1s-[1alpha(2s*,3r*), 9alpha]6, 10-dioxo-n-(2-ethoxy-5-oxo-tetrahydro-3-furanyl)-9[[(1-isoquinolyl) carbonyl]amino]octahydro-6h-piridazino[1,2-a][1,2]diazepin-1-carboxamide
09/20/2005US6946129 Recombinant anti-CD40 antibody and uses thereof
09/15/2005WO2005085294A1 Hyaluronic acid/methotrexate compound
09/15/2005WO2005085275A1 Inhibitors of hepatitis c virus ns3 protease
09/15/2005WO2005085242A1 Novel ketoamides with cyclic p4's as inhibitors of ns3 serine protease of hepatitis c virus
09/15/2005WO2005085236A2 Caspase inhibitors and uses thereof
09/15/2005WO2005085197A1 Cyclobutenedione groups-containing compounds as inhibitors of hepatitis c virus ns3 serine protease
09/15/2005WO2005054430A3 Hepatitis c virus inhibitors
09/15/2005WO2004064770A3 Use of smad3 inhibitor in the treatment of fibrosis dependent on epithelial to mesenchymal transition as in the eye and kidney
09/15/2005US20050203165 Perfectly reproducible crystalline form that especially exhibits valuable characteristics for formulation of inhibitors of angiotensin I converting enzyme; preparation from a solution of the salt in CH2Cl2 or ethyl acetate; treating cardiovascular disease
09/15/2005US20050203031 Useful for the treatment of type 2 diabetes, impaired glucose tolerance and certain other conditions
09/15/2005US20050203030 Novel effectors of dipeptidyl peptidase IV
09/15/2005US20050203028 Method of preparing peptide
09/15/2005US20050203027 Reduced toxicity, improved specificity for targeted protease
09/15/2005US20050202027 Multivalent compounds for crosslinking receptors and uses thereof
09/15/2005CA2820541A1 Caspase inhibitors and uses thereof
09/15/2005CA2559188A1 Hyaluronic acid-methotrexate conjugate
09/15/2005CA2558664A1 Functional method for generating or screening for ligands which modulate steroid hormone receptors
09/15/2005CA2557645A1 Caspase inhibitors and uses thereof
09/15/2005CA2557322A1 Inhibitors of hepatitis c virus ns3 protease
09/15/2005CA2557304A1 Ketoamides with cyclic p4's as inhibitors of ns3 serine protease of hepatitis c virus
09/15/2005CA2557301A1 Cyclobutenedione groups-containing compounds as inhibitors of hepatitis c virus ns3 serine protease
09/14/2005EP1574516A1 Antithrombotic compound
09/14/2005EP1574507A2 Furo- and pyrano-naphthoquinones and their use in the treatment of cancer
09/14/2005EP1573323A2 Prion protein ligands and methods of use
09/14/2005EP1573025A2 Crystallized structure of type iv collagen nc1 domain hexamer
09/14/2005EP1573024A2 Nuleic acids and corresponding proteins useful in the detection and treatment of various cancers
09/14/2005EP1573023A2 Nucleic acid and corresponding protein entitled 162p1e6 useful in treatment and detection of cancer
09/14/2005EP1572720A2 Method for enzymatic production of glp-2(1-33) and glp-2-(1-34) peptides
09/14/2005EP1572719A2 Partial peptide mimetics and methods
09/14/2005EP1572717A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
09/14/2005EP1572645A2 Derivatives of succinic and glutaric acids and analogs thereof useful as inhibitors of phex
09/14/2005EP1572168A2 Anti-infarction molecules
09/14/2005EP1572149A2 Immunogenicity of glucan binding protein
09/14/2005EP1572076A2 Helical peptidomimetics
09/14/2005EP1572066A2 Novel method and composition for inhibition of angiogenesis and tumor growth using compounds based on a sequence within mmp-2
09/14/2005EP1572064A2 Pharmaceutical compositions comprising modified cns-derived peptides for promoting nerve regeneration and prevention of nerve degeneration
09/14/2005EP0813543B1 Bis-amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors
09/14/2005CN1668336A Drug transport and delivery system
09/14/2005CN1668297A 丙型肝炎病毒抑制剂 Hepatitis C virus inhibitors
09/14/2005CN1218943C 4-pyrimidine-N-acyl-L-phenylalanines compound
09/13/2005US6943180 Substituted N-arylsulfonyl-proline derivatives as potent cell adhesion inhibitors
09/13/2005US6943170 N-cycloalkylglycines as HIV protease inhibitors
09/13/2005US6943149 Thrombosis, restenosis, hypertension, heart failure, arrhy-thmia, inflammation, angina, stroke, atherosclerosis, cancer, ischemic conditions, angiogenesis related disorders, neuro-degenerative disorders
09/13/2005US6943147 Cancer treatment using proANP peptides
09/13/2005CA2426703C Therapeutic agents and methods of use thereof for the modulation of angiogenesis
09/12/2005CA2458084A1 Novel process for octreotide synthesis
09/09/2005WO2005082927A2 Antihypertensive peptides
09/09/2005WO2005082348A2 Inhibitors of dipeptidylpeptidase iv for regulating glucose metabolism
09/09/2005WO2005051410B1 Hepatitis c virus inhibitors
09/09/2005CA2841741A1 Monomethylvaline compounds capable of conjugation to ligands
09/09/2005CA2558155A1 Casein derived peptides and therapeutic uses thereof
09/09/2005CA2558106A1 Inhibitors of dipeptidylpeptidase iv for regulating glucose metabolism
09/09/2005CA2556893A1 Antihypertensive peptides
09/09/2005CA2556830A1 Methods and compositions comprising non-peptide small molecules that solubilize beta amyloid peptide fiber
09/09/2005CA2555583A1 Positive modulator of bone morphogenic protein-2
09/09/2005CA2543888A1 Monomethylvaline compounds capable of conjugation to ligands
09/08/2005US20050197301 3,4-(cyclopentyl)-fused proline compounds as inhibitors of hepatitis C virus NS3 serine protease
09/08/2005US20050197299 Peptidomimetic protease inhibitors
09/07/2005EP1571154A1 Beta-aminoacid-derivatives as factor Xa inhibitors
09/07/2005EP1569954A1 Cyanomethyl derivatives as cysteine protease inhibitors
09/07/2005EP1569953A1 Peptide gap junction modulators
09/07/2005EP1569895A1 Prodrugs of gaba analogs, compositions and uses thereof
09/07/2005EP1432432A4 A cancer treatment system
09/07/2005CN1665833A Novel variants of the PapM polypeptide of bacteria of genus streptomyces
09/07/2005CN1665832A Process for producing sugar peptide having asparagine sugar chain and the sugar peptide
09/07/2005CN1665831A Novel compounds, compositions as carriers for steroid/nonsteroid anti-inflammatory; antienoplastic and antiviral active molecules
09/06/2005US6939987 N-(N-(3-(3-methoxy-4-hydroxyphenyl)propyl)-L-alpha-aspartyl)-L -phenylalanine 1-methyl ester prepared by reacting aspartame with 3-(3-methoxy-4-hydroxyphenyl) propionaldehyde; artificial sweetener
09/06/2005US6939967 Non-proteinogenic L-amino acids
09/06/2005US6939948 blocks the binding of an anti-GD2 antibody to a tumor cell expressing GD2 ganglioside; elicit an immune response against a tumor associated antigen that is not normally immunogenic
09/06/2005US6939880 Compounds with growth hormone releasing properties
1 ... 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 ... 307